Representative Matters
Represented EQ Inc., a leader in geospatial data and artificial intelligence driven software, in its acquisition of the shares of Integrated Rewards Inc., and its consumer-facing application Paymi.com.
Advised Melchior Management 777 Corporation in the formation of a new private residential REIT consisting of 38 multi-family properties totalling 1,260 residential units located throughout southern Ontario.
Advised MediPharm Labs Corp., a leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, in the completion of a $33 million bought deal offering.
Represented PsyBio Therapeutics, Inc., a biotechnology company developing a new class of drugs intended for the potential treatment of mental health challenges and other disorders, in the completion of its reverse takeover of PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV:PSYB) and related private placement offering of subscription receipts for aggregate gross proceeds of $14.5 million.
Represented EQ Inc., in the completion of its overnight marketed offering of an aggregate of 7,187,500 common shares in the capital of the Company at a price of $1.60 per Offered Security for total gross proceeds of $11.5 million.
Represented Harborside Inc., a California-focused, vertically-integrated cannabis enterprise, in the completion of a brokered private placement offering of units for aggregate gross proceeds of approximately $35 million.
Represented Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto, in its completion of a $600 million debt offering of 1.726% series H senior unsecured debentures. The Series H Debentures are Allied’s inaugural Green Bond issuance under its recently announced Green Financing Framework.
Represented Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, in the completion of a bought deal short form prospectus offering of units for aggregate gross proceeds of approximately $34 million.
Represented Cybin Inc. (the “Company”) (NEO: CYBN) in the completion of its reverse takeover of Clarmin Explorations Inc. pursuant to the terms of an amalgamation agreement among Cybin Corp., Clarmin and a wholly-owned subsidiary of the Company as well as a private placement offering of 60 million subscription receipts for aggregate gross proceeds of $45 million.
Represented Baylin Technologies Inc. (TSX:BYL), a leading, diversified, global technology company, in its completion of a private placement offering of 6,666,700 units at a price of $0.75 per unit for aggregate gross proceeds of approximately $5 million.
Represented Energy+ Inc. in the closing of a $55 million offering of 2.968% senior unsecured debentures due August 10, 2060. The debentures were sold on an agency basis to accredited investors on a private placement basis by means of a confidential offering memorandum.
Represented MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, in its completion of a $37.8 million private placement with an institutional investor.
Represented Allied Properties Real Estate Investment Trust in its completion of a $300 million debt offering.
Represented Allied Properties Real Estate Investment Trust in its completion of a $400 million debt offering.
Represented Allied Properties Real Estate Investment Trust in its completion of a $345 million public equity offering of units.
Represented Pistil Partners Inc. in the completion of a private placement of its common shares and acquisition of Ironside Hemp Company Inc., a private U.S.-based hemp management company.
Represented MediPharm Labs Inc., a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, in the completion of a $75 million bought deal offering.